Basic Information
Gynesonics is a women's healthcare company dedicated to minimally invasive solutions for symptomatic uterine fibroids. Gynesonics has developed the Sonata™ system for transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The Sonata™ system bears the CE mark and has been approved for sale in the European Union. The Sonata™ system is not sold in the United States. Gynesonics has developed an ablation device for the treatment of uterine fibroids.
Gynesonics, Inc.
California,United States of America
15~50 people
January 01, 2005
info@gynesonics.com

